(PharmaNewsWire.Com, June 10, 2017 ) Diarrhea is a contagious gastrointestinal infection occurring mostly due to unhygienic conditions. Diarrhea may be related to a viral or bacterial infection and is sometimes the result of food poisoning. Symptoms include nausea, abdominal pain, cramping, bloating, dehydration, fever, bloody stools, frequent urge to evacuate the bowels and incontinence. Treatment includes medication and healthy lifestyle.
Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Diarrhea - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Diarrhea (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Diarrhea (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Diarrhea and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 5, 15, 2, 21 and 6 respectively. Similarly, the Universities portfolio in Phase I and Preclinical stages comprises 2 and 4 molecules, respectively.
Diarrhea (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
- The pipeline guide provides a snapshot of the global therapeutic landscape of Diarrhea (Gastrointestinal). - The pipeline guide reviews pipeline therapeutics for Diarrhea (Gastrointestinal) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. - The pipeline guide reviews key companies involved in Diarrhea (Gastrointestinal) therapeutics and enlists all their major and minor projects. - The pipeline guide evaluates Diarrhea (Gastrointestinal) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. - The pipeline guide encapsulates all the dormant and discontinued pipeline projects. - The pipeline guide reviews latest news related to pipeline therapeutics for Diarrhea (Gastrointestinal)
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. - Find and recognize significant and varied types of therapeutics under development for Diarrhea (Gastrointestinal). - Classify potential new clients or partners in the target demographic. - Develop tactical initiatives by understanding the focus areas of leading companies. - Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics. - Formulate corrective measures for pipeline projects by understanding Diarrhea (Gastrointestinal) pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Key Company profiles
A. Menarini Industrie Farmaceutiche Riunite Srl Actelion Ltd Aegis Therapeutics LLC Akthelia Pharmaceuticals Ltd Albireo Pharma Inc AmpliPhi Biosciences Corp Anatara Lifesciences Limited Ardelyx Inc Assembly Biosciences Inc AzurRx BioPharma Inc Bharat Biotech International Ltd CinRx Pharma LLC Codagenix Inc Cosmo Pharmaceuticals NV DesignMedix Inc DiscoveryBiomed Inc Genextra Spa GlaxoSmithKline Plc GP Pharm SA Miyarisan Pharmaceutical Company Ltd Mucosis BV Napo Pharmaceuticals Inc Nippon Shinyaku Co Ltd Novartis AG Pfizer Inc Prokarium Ltd Rebiotix Inc Recce Ltd RedHill Biopharma Ltd RxBio Inc Scandinavian Biopharma Holding AB Sigmoid Pharma Ltd Summit Therapeutics Plc Synthetic Biologics Inc Syntiron LLC Tasly Pharmaceutical Group Co Ltd Wuhan Institute of Biological Products Co Ltd
Number of Products under Development for Diarrhea, H1 2017 Number of Products under Development by Companies, H1 2017 Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017 Number of Products under Development by Companies, H1 2017 (Contd..2), H1 2017 Number of Products under Development by Universities/Institutes, H1 2017 Products under Development by Companies, H1 2017 Products under Development by Companies, H1 2017 (Contd..1), H1 2017 Products under Development by Companies, H1 2017 (Contd..2), H1 2017 Products under Development by Universities/Institutes, H1 2017 Number of Products by Stage and Target, H1 2017 Number of Products by Stage and Target, H1 2017 (Contd..1), H1 2017 Number of Products by Stage and Mechanism of Action, H1 2017 Number of Products by Stage and Route of Administration, H1 2017 Number of Products by Stage and Molecule Type, H1 2017 Diarrhea - Pipeline by A. Menarini Industrie Farmaceutiche Riunite Srl, H1 2017 Diarrhea - Pipeline by Actelion Ltd, H1 2017 Diarrhea - Pipeline by Aegis Therapeutics LLC, H1 2017 Diarrhea - Pipeline by Akthelia Pharmaceuticals Ltd, H1 2017 Diarrhea - Pipeline by Albireo Pharma Inc, H1 2017 Diarrhea - Pipeline by AmpliPhi Biosciences Corp, H1 2017 Diarrhea - Pipeline by Anatara Lifesciences Limited, H1 2017 Diarrhea - Pipeline by Ardelyx Inc, H1 2017 Diarrhea - Pipeline by Assembly Biosciences Inc, H1 2017 Diarrhea - Pipeline by AzurRx BioPharma Inc, H1 2017 Diarrhea - Pipeline by Bharat Biotech International Ltd, H1 2017 Diarrhea - Pipeline by CinRx Pharma LLC, H1 2017 Diarrhea - Pipeline by Codagenix Inc, H1 2017 Diarrhea - Pipeline by Cosmo Pharmaceuticals NV, H1 2017 Diarrhea - Pipeline by DesignMedix Inc, H1 2017 Diarrhea - Pipeline by DiscoveryBiomed Inc, H1 2017 Diarrhea - Pipeline by Genextra Spa, H1 2017 Diarrhea - Pipeline by GlaxoSmithKline Plc, H1 2017 Diarrhea - Pipeline by GP Pharm SA, H1 2017 Diarrhea - Pipeline by Miyarisan Pharmaceutical Company Ltd, H1 2017 Diarrhea - Pipeline by Mucosis BV, H1 2017 Diarrhea - Pipeline by Napo Pharmaceuticals Inc, H1 2017 Diarrhea - Pipeline by Nippon Shinyaku Co Ltd, H1 2017 Diarrhea - Pipeline by Novartis AG, H1 2017 Diarrhea - Pipeline by Pfizer Inc, H1 2017 Diarrhea - Pipeline by Prokarium Ltd, H1 2017 Diarrhea - Pipeline by Rebiotix Inc, H1 2017 Diarrhea - Pipeline by Recce Ltd, H1 2017 Diarrhea - Pipeline by RedHill Biopharma Ltd, H1 2017 Diarrhea - Pipeline by RxBio Inc, H1 2017 Diarrhea - Pipeline by Scandinavian Biopharma Holding AB, H1 2017 Diarrhea - Pipeline by Sigmoid Pharma Ltd, H1 2017 Diarrhea - Pipeline by Summit Therapeutics Plc, H1 2017 Diarrhea - Pipeline by Synthetic Biologics Inc, H1 2017 Diarrhea - Pipeline by Syntiron LLC, H1 2017 Diarrhea - Pipeline by Tasly Pharmaceutical Group Co Ltd, H1 2017 Diarrhea - Pipeline by Wuhan Institute of Biological Products Co Ltd, H1 2017 Diarrhea - Dormant Projects, H1 2017 Diarrhea - Dormant Projects, H1 2017 (Contd..1), H1 2017 Diarrhea - Discontinued Products, H1 2017
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
